Pharmacokinetic Studies on Diclofenac Sodium in Young and Old Volunteers
- 1 January 1978
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Rheumatology
- Vol. 7 (sup22) , 36-41
- https://doi.org/10.3109/03009747809097214
Abstract
A single 50 mg enteric-coated tablet of diclofenac sodium (Voltaren®) was administered to two groups, each consisting of eight female subjects. The subjects in the one group were young adults all aged less than 22 years, while those in the other were all over the age of 62 years. The plasma concentration/time profiles, relative bio-availability, and urinary excretion pattern of the drug in the two groups were similar. Thus, in the absence of interacting factors, such as drugs and disease, the ability to absorb, metabolise, and excrete diclofenac sodium does not appear to be influenced by age.This publication has 9 references indexed in Scilit:
- Pharmacokinetics and Metabolism of the Anti-Inflammatory Agent VoltarenScandinavian Journal of Rheumatology, 1978
- PLASMA-PROPRANOLOL LEVELS IN INFLAMMATORY DISEASEThe Lancet, 1976
- Quantitative assay of diclofenac in biological material by gas—liquid chromatographyJournal of Chromatography A, 1975
- The effect of ageing on plasma pethidine concentration.Published by Wiley ,1975
- The effect of age on plasma levels of propranolol and practolol in man.British Journal of Clinical Pharmacology, 1975
- Pharmacokinetics in the elderlyEuropean Journal of Clinical Pharmacology, 1975
- Drug interactions: Clinical significanceClinical Pharmacology & Therapeutics, 1974
- Effect of Age and Sex on Human Drug MetabolismBMJ, 1971
- RENAL EXCRETION OF DRUGS IN THE ELDERLYThe Lancet, 1970